换一批
换一批Long-term safety and, tolerability profiles and lipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment: a multicenter, randomized, double-blind, placebo-controlled, 48-week extension study.
作者：
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗胆固醇血症药(Anticholesteremic Agents);吖丁啶类(Azetidines);双盲法(Double-Blind Method);药物疗法, 联合(Drug Therapy, Combination);女(雌)性(Female);人类(Humans);高胆固醇血症(Hypercholesterolemia);脂蛋白类(Lipoproteins);男(雄)性(Male);中年人(Middle Aged);斯伐他汀(Simvastatin);时间因素(Time Factors)
DOI
10.1016/j.clinthera.2005.02.011
PMID
15811480
发布时间
2015-11-19
- 浏览6
Clinical therapeutics
174-84页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
